Arena Pharmaceuticals announced, as expected, the U.S. Food and Drug Administration did not approve its weight loss drug Lorcaserin for patients who are obese and overweight because the potential risks outweigh the minimal effi…
Another diet drug, Arena Pharmaceuticals’s Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.
Continue reading FDA Panel Votes Against Aren…
It’s a busy day at the FDA today as panels meet to discuss two new drugs — one to help weight loss and the other to combat drug addiction — and decide whether to approve AstraZeneca’s new blood thinner medication.
…